http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150102383-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_236a1ba293866816074754dfff946e5c |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1358 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0639 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 |
filingDate | 2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a785e4a8f40f5c7940b5ec8beb3d8811 |
publicationDate | 2015-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20150102383-A |
titleOfInvention | The culture method for autologous immune cells manipulation with ex vivo |
abstract | The present invention relates to a method for culturing an autologous immune cell for the production of a living cell manipulated with EX VIVO, which comprises a method for producing dendritic cells improved in immunosuppressive ability by mesenchymal stem cells, , And pharmaceutical compositions comprising such dendritic cells. The autologous immune cells of the present invention with improved immunosuppressive ability can be used for the treatment of various diseases or diseases that can be treated through the immunosuppressive mechanism and the immune cells of the present invention having improved immunotolerance ability , Enabling effective application as an immunosuppressive agent for dendritic cells. |
priorityDate | 2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 291.